Breaking News

Sunday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
XLRN

Acceleron

$36.04

-0.08 (-0.22%)

, ARQL

ArQule

$5.00

-0.31 (-5.84%)

04:55
06/17/18
06/17
04:55
06/17/18
04:55
Conference/Events
European Hematology Association to hold a conference »

23rd Congress of the EHA…

XLRN

Acceleron

$36.04

-0.08 (-0.22%)

ARQL

ArQule

$5.00

-0.31 (-5.84%)

EPZM

Epizyme

$15.00

-0.85 (-5.36%)

KPTI

Karyopharm

$18.65

0.6 (3.32%)

APLS

Apellis

$22.34

0.26 (1.18%)

BLUE

Bluebird Bio

$182.75

-13.95 (-7.09%)

TGTX

TG Therapeutics

$13.75

-0.05 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

Saturday
XLRN

Acceleron

$36.04

-0.08 (-0.22%)

, ARQL

ArQule

$5.00

-0.31 (-5.84%)

04:55
06/16/18
06/16
04:55
06/16/18
04:55
Conference/Events
European Hematology Association to hold a conference »

23rd Congress of the EHA…

XLRN

Acceleron

$36.04

-0.08 (-0.22%)

ARQL

ArQule

$5.00

-0.31 (-5.84%)

EPZM

Epizyme

$15.00

-0.85 (-5.36%)

KPTI

Karyopharm

$18.65

0.6 (3.32%)

APLS

Apellis

$22.34

0.26 (1.18%)

BLUE

Bluebird Bio

$182.75

-13.95 (-7.09%)

TGTX

TG Therapeutics

$13.75

-0.05 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jun

  • 20

    Jun

Friday
EPZM

Epizyme

$15.85

0.15 (0.96%)

07:25
06/15/18
06/15
07:25
06/15/18
07:25
Conference/Events
Epizyme to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

EPZM

Epizyme

$15.85

0.15 (0.96%)

05:56
06/15/18
06/15
05:56
06/15/18
05:56
Hot Stocks
Epizyme reports updated interim data from Phase 2 study of tazemetostat »

Epizyme announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

XLRN

Acceleron

$36.12

0.19 (0.53%)

, ARQL

ArQule

$5.31

-0.21 (-3.80%)

04:55
06/15/18
06/15
04:55
06/15/18
04:55
Conference/Events
European Hematology Association to hold a conference »

23rd Congress of the EHA…

XLRN

Acceleron

$36.12

0.19 (0.53%)

ARQL

ArQule

$5.31

-0.21 (-3.80%)

EPZM

Epizyme

$15.85

0.15 (0.96%)

KPTI

Karyopharm

$18.05

0.54 (3.08%)

APLS

Apellis

$22.08

0.02 (0.09%)

BLUE

Bluebird Bio

$196.70

8.4 (4.46%)

TGTX

TG Therapeutics

$13.80

0.35 (2.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

  • 15

    Jun

  • 15

    Jun

  • 20

    Jun

Over a week ago
XLRN

Acceleron

$35.93

0.57 (1.61%)

, ARQL

ArQule

$5.52

0.34 (6.56%)

08:38
06/14/18
06/14
08:38
06/14/18
08:38
Conference/Events
European Hematology Association to hold a conference »

23rd Congress of the EHA…

XLRN

Acceleron

$35.93

0.57 (1.61%)

ARQL

ArQule

$5.52

0.34 (6.56%)

EPZM

Epizyme

$15.70

-0.3 (-1.88%)

KPTI

Karyopharm

$17.51

0.22 (1.27%)

APLS

Apellis

$22.06

1.42 (6.88%)

BLUE

Bluebird Bio

$188.30

3.5 (1.89%)

TGTX

TG Therapeutics

$13.45

-0.1 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 15

    Jun

  • 15

    Jun

  • 20

    Jun

EPZM

Epizyme

$16.45

0.25 (1.54%)

10:02
06/12/18
06/12
10:02
06/12/18
10:02
Conference/Events
Epizyme to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 15

    Jun

EPZM

Epizyme

$17.15

-0.25 (-1.44%)

16:59
06/03/18
06/03
16:59
06/03/18
16:59
Hot Stocks
Epizyme presents Phase 2 data of Tazemetostat for Malignant Mesothelioma »

Epizyme announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 14

    Jun

  • 15

    Jun

EPZM

Epizyme

$18.45

0.3 (1.65%)

16:02
05/24/18
05/24
16:02
05/24/18
16:02
Hot Stocks
Epizyme treatment of chordoma granted FDA orphan designation »

Epizyme's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

Over a month ago
EPZM

Epizyme

$16.95

0.7 (4.31%)

07:36
05/18/18
05/18
07:36
05/18/18
07:36
Recommendations
Epizyme analyst commentary at Wedbush »

Epizyme price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.